One major consequence of this signaling in the gut is increased production of prostaglandin E2 (PGE2) via cyclooxygenase-2 (COX-2) induction in myofibroblasts, which has been reported to be dependent on Ca 2ϩ . In this study, we explored a potential role of canonical transient receptor potential (TRPC) proteins in this Ca 2ϩ -mediated signaling using a human colonic myofibroblast cell line CCD-18Co. In CCD-18Co cell, treatment with TNF-␣ greatly enhanced Ca 2ϩ influx induced by store depletion along with increased cell-surface expression of TRPC1 protein (but not of the other TRPC isoforms) and induction of a Gd 3ϩ -sensitive nonselective cationic conductance. Selective inhibition of TRPC1 expression by small interfering RNA (siRNA) or functionally effective TRPC1 antibody targeting the near-pore region of TRPC1 (T1E3) antagonized the enhancement of store-dependent Ca 2ϩ influx by TNF-␣, whereas potentiated TNF-␣ induced PGE2 production. Overexpression of TRPC1 in CCD-18Co produced opposite consequences. Inhibitors of NF-B (curcumin, SN-50) attenuated TNF-␣-induced enhancement of TRPC1 expression, store-dependent Ca 2ϩ influx, and COX-2-dependent PGE2 production. In contrast, inhibition of calcineurin-nuclear factor of activated T-cell proteins (NFAT) signaling by FK506 or NFAT Activation Inhibitor III enhanced the PGE 2 production without affecting TRPC1 expression and the Ca 2ϩ influx. Finally, the suppression of store-dependent Ca 2ϩ influx by T1E3 antibody or siRNA knockdown significantly facilitated TNF-␣-induced NF-B nuclear translocation. In aggregate, these results strongly suggest that, in colonic myofibroblasts, NF-B and NFAT serve as important positive and negative transcriptional regulators of TNF-␣-induced COX-2-dependent PGE 2 production, respectively, at the downstream of TRPC1-associated Ca 2ϩ influx. Ca 2ϩ signaling; nuclear factor of activated T-cell proteins; NF-B; cytokine; inflammation; transient receptor potential; cyclooxygenase-2 SUBEPITHELIAL MYOFIBROBLASTS are located at the interface between the epithelium and lamina propria in most mucosal tissues. They have ultrastructural features reminiscent of both smooth muscle cells and fibroblasts (40) . A growing body of evidence has been accumulated that myofibroblasts play crucial roles in intestinal homeostasis, inflammation, and neoplasia. The major mediator produced in myofibroblasts is prostaglandin E 2 (PGE 2 ), which plays both protective and destructive roles in the gut. Although genetic deletion of the PGE 2 receptor EP4 is detrimental to the gut, high concentrations of PGE 2 analogs are also shown to exacerbate clinical colitis leading to tumorigenicity, presumably through the induction of proinflammatory responses (12, 33, 36) . The formation of PGE 2 in myofibroblasts is catalyzed mainly by cyclooxygenase-2 (COX-2), which is distinct from another isoform COX-1. COX-1 is a housekeeping enzyme and is constitutively expressed in most tissues, whereas COX-2 is expressed at low levels under unstimulated conditions but is rapidly induced upon inflammation and proliferation in response to cytokines, growth factors, and tumor promoters (35) . The rate of PGE 2 production is significantly enhanced via induction of COX-2 by tumor necrosis factor-␣ (TNF-␣), which is central to the inflammation and acts as an endogenous tumor promoter (15) . Therapeutic antibodies against TNF-␣ exert dramatic ameliorating effects on inflammatory bowel syndrome, in which myofibroblasts are found to play a vital role (4) .
The myofibroblast cell line CCD-18Co was established from the mucosal tissue of human colon. CCD-18Co expresses COXs and secretes PGE 2 , the rate of which is significantly enhanced by TNF-␣ or interleukin-1␤ (IL-1␤) (14) . There is evidence that COX-2 expression and PGE 2 production in myofibroblasts are controlled by intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) (25, 47) . However, what sources of Ca 2ϩ contribute thereto remain entirely unclear. In general, there are two distinct sources for Ca 2ϩ that can elevate [Ca 2ϩ ] i , i.e., Ca 2ϩ influx across the plasma membrane and Ca 2ϩ release from the endoplasmic reticulum (ER). Ca 2ϩ influx can occur through voltage-gated (VGC), receptor-operated (ROC), and storeoperated Ca 2ϩ channels (SOC). Recent studies have shown that the canonical members of the transient receptor potential (TRPC) proteins may contribute to SOC and ROC. The TRPC family consists of seven distinct isoforms designated as TRPC1-TRPC7 (1, 8, 10, 30) . Presently, TRPC1 is regarded as one of plausible candidate molecules for SOC in many cell types (1, 30) although early studies in T-lymphocytes and other hematopoietic cells demonstrated that the molecular identification of the bona fide SOC pore-forming subunit is Orai1 (9) . Recent evidence suggests that the Ca 2ϩ -transporting activity of these SOC molecules is regulated by an ER Ca 2ϩ sensor protein, the stromal interacting molecule 1 (STIM1), which relays the store depletion signal to the plasma membrane to activate SOC (19, 32, 46) . In some cell types, TRPC1 dynamically assembles with both STIM1 and Orai1 to generate more complexity in store-dependent Ca 2ϩ influx mechanisms (27) although whether TRPC1 serves as a pore-forming subunit of SOC still remains unclear.
The nuclear factor of activated T-cell proteins (NFATs) and the NF-B are widely distributed, Ca 2ϩ -dependent transcription factors that regulate a multitude of physiological and pathophysiological processes (3, 39, 44) . NFAT is activated via dephosphorylation by calcineurin, which is activated upon binding of Ca 2ϩ /calmodulin. NFAT has been reported to regulate COX-2 expression in colon carcinoma cells (5) , and its activation can occur through Ca 2ϩ influx associated with TRPC1-, TRPC3-, or TRPC6-associated SOC or ROC activities (26, 38) . On the other hand, the activation of NF-B is initiated by the phosphorylation of IB (inhibitors of NF-B) proteins, which under unstimulated conditions prevent the nuclear localization of the p65 protein, a subunit of inactive NF-B dimer. When phosphorylated on serine residues in response to proinflammatory stimuli, IBs are ubiquitinated and then degraded by the proteasome (2, 13) . In human gingival fibroblasts, TNF-␣-induced PGE 2 release has been assigned to COX-2 induction via an NF-B-dependent pathway (23) . Furthermore, the transcriptional upregulation of TRPC1 via TNF-␣-NF-B signaling has been reported in endothelial cells (29) . Conversely, in epithelial cells, increased TRPC1 expression inhibits NF-B activity as a result of enhanced Ca 2ϩ influx (20, 21) . In this study, on the basis of the above knowledge, we hypothesized that in gut myofibroblasts TNF-␣ may stimulate COX-2-dependent PGE 2 production via enhanced [Ca 2ϩ ] i dynamics through activation of TRPC channels. To test this hypothesis, we investigated the effects of TNF-␣ on the expression level of TRPC proteins and associated Ca 2ϩ transporting activities. We further examined their impacts on PGE 2 production in CCD-18Co myofibroblast, with particular interest in the regulation of Ca 
MATERIALS AND METHODS
Cell culture. Human colonic subepithelial myofibroblast cell line, CCD-18Co, was purchased from the American Type Culture Collection (CRL-1459) and grown in MEM supplemented with 10% FBS, 2 mM L-glutamine, and 0.1 mM nonessential amino acids. CCD-18Co myofibroblasts were passaged 12 to 17 times and, when necessary, transfected with the stealth siRNA of TRPC1 or full-length human TRPC1 cDNA inserted into the pCIneo vector by the aid of a transfectant Lipofectamine 2000 (Invitrogen).
RT-PCR. Total RNA extracted from CCD-18Co cells was subjected to semiquantitative RT-PCR using the following protocol: preheating at 94°C for 1 min followed by 20, 30, or 35 cycles of denature at 94°C for 10 s, annealing at 58 -65°C for 30 s and extension at 72°C for 1 min, and final extension at 72°C for 10 min. RNA extract from whole rat brain was used as a positive control. Primer pairs used for each TRPC isoform are listed in Table 1 . PCR amplicons were electrophoresed and visualized by SYBR Green (Qiagen).
PGE2 immunoassay. CCD-18Co myofibroblasts were seeded at the density of 5 ϫ 10 5 cells/cm 2 and grown to confluence in a 24-well culture plate filled with MEM containing 10% FBS, 2 mM L-glutamine, and 0.1 mM nonessential amino acids. After being cultured for 24 h at 37°C in the presence or absence of drugs listed below, cells were washed with Dulbecco's PBS (Sigma). After being incubated in fresh prewarmed PBS at 37°C, the resulting supernatant was collected and immediately frozen at Ϫ80°C. The remaining cells were collected to measure protein concentration. PGE 2 levels were determined for appropriately diluted supernatants by using a PGE 2 enzyme immunoassay kit (R&D Systems) according to the manufacturer's instructions. The obtained values were normalized and expressed per unit of protein weight to minimize variations among different experimental conditions. According to the manufacturer's information, the antibody used in the PGE2 immunoassay crossreacts 17.5% with PGE3, 11.9% with PGE 1, 7.0% with PGF1␣, 6.0% with PGF2␣, 2.5% with 6-keto-PGF 1␣, but negligibly with the other eicosanoid pathway products.
Immunoblot analysis. Immunoblotting experiments were performed to examine the protein level of TRPC1, STIM1, Orai1, COX-2, NFAT3, IB-␣, and NF-B/p65 in CCD-18Co myofibroblasts. Total cell lysates were prepared in sample buffer. Cytoplasmic and nuclear proteins were extracted from CCD-18Co cells by using the ProteoJET, a cytoplasmic and nuclear protein extraction kit (Fermentas), according to the manufacturer's instructions. Protein concentrations of samples were determined using a BCA protein assay kit (Pierce). Just before electrophoresis, 5% (vol/vol) 2-mercaptoethanol and 1% (wt/vol) bromophenol blue were added to the sample, and proteins were separated by 10% (wt/vol) SDS-PAGE and electrophoretically transferred to a PVDF membrane. The membrane was blocked with 5% (wt/vol) skim milk dissolved in Tween-PBS and then incubated overnight with anti-TRPC1 antibody (Alomone) (1: 200), anti-Na ϩ /K ϩ ATPase-␣1 (NKA) antibody (Upstate) (1:500), anti-COX-2 antibody (BD Transduction Laboratories) (1:200), anti-␤-actin antibody (Abcam) (1:2,000), anti-GOK/STIM1 antibody (BD Transduction Laboratories) (1:500), anti-Orai1 antibody (Alomone) (1:200), anti-NFAT3 antibody (Cell Signaling) (1:1,000), anti-IB-␣ antibody (Cell Signaling) (1:1,000), anti-NF-B p65 antibody (Cell Signaling) (1:1,000), or anti-Lamin B antibody (Santa Cruz Biotechnology) (1:1,000), respectively. Protein expressions were detected by incubating the PVDF membrane with respective secondary antibodies linked to horseradish peroxidase. Cell surface biotinylation assay. CCD-18Co cells were washed once with ice-cold PBS and added to 0.5 mg/ml EZ-Link Sulfo-NHS-SS-Biotin (Pierce) for 30 min on ice. Thereafter, biotin was quenched with 50 mM glycine on ice for 10 -15 min. The cells were lysed using 500 l of lysis buffer containing the following: 500 mM NaCl, 10 mM Tris·HCl, 1 mM EDTA, 0.2 mM sodium vanadate, 0.2 mM phenylmethylsulfonyl fluoride, 0.5% Nonidet P-40, 10% sucrose, and 1 g/ml aprotinin leupeptin (pH 7.5). The cell extracts were sonicated for 10 s six times, and insoluble material was spun down at 30,000 g for 20 min. Immobilized avidin beads (20 l) (Sigma) in PBS were added to a 100-l aliquot of cell extract and incubated on a rotator overnight at 4°C. The bound fraction was washed and released in SDS-PAGE sample buffer and analyzed by Western blotting with anti-TRPC1 or anti-NKA antibody as described above. NKA was used as an internal control of biotin-labeled membrane fraction.
Measurement of [Ca 2ϩ ]i. The intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) of myofibroblasts was monitored by the fura-2 digital fluorescence imaging technique. Briefly, CCD-18Co myofibroblasts were plated on a poly-L-lysine-coated glass chamber placed on the stage of an inverted fluorescent microscope (DMI600B, Leica Microsystems). The cells were then loaded with fura-2 AM (5 M with 0.01% pluronic acid) in the dark at room temperature for 30 min. The intensity of fura-2 fluorescence emitted at 510 nm (Ϯ10 nm) by 340-or 380-nm excitation was measured by means of a digital photoimaging system composed of a fluorescent microscope (DMI600B, Leica) and a low-noise, high-intensifying EMCCD camera (Cascade, Nippon Roper). The data acquisition and analysis were made by the software SlideBook 4.2 (Intelligent Imaging Innovation). The obtained fluorescence was corrected for background fluorescence, and changes in [Ca 2ϩ ]i were defined as the ratio of corrected fluorescence intensities at 340 and 380 nm, respectively (F340/F380). To evaluate the magnitude of Ca 2ϩ entry in CCD-18Co cells, they were first perfused with Ca 2ϩ -free external solution containing cyclopiazonic acid (CPA; 10 M) and then exposed to 1 mM Ca 2ϩ re-introduced into the bath.
Electrophysiology. Patch electrodes of 4 -5 M⍀ in resistance were fabricated by an automated puller (Sutter Instruments) and heatpolished by an iridium-wired microforge. Voltages were applied, and current signals were acquired through a high-impedance low-noise patch clamp amplifier (EPC9, HEKA Electronics), which was controlled by an A/D, D/A-converter (Digidata 1200, Axon Instruments) driven by the pClamp v.6 software (Axon Instruments). For long-time recordings, the current signals were low-pass-filtered at 100 Hz and digitized at 1 kHz by using PowerLab/400 (AD Instruments; sampling rate: 100 Hz) and analyzed by the software Chart v.5. The mean magnitude of recorded currents was evaluated as the average over 5-10 s. To construct the current-voltage relationships, rising ramp voltages (Ϫ100 -100 mV, 2 s in duration) were applied to cells, and corresponding currents were sampled at 3 kHz after 1-kHz low-pass filtering and analyzed by the Clampfit v.9.2 software (Axon Instruments).
Drugs were rapidly applied onto cells by using a fast solutionchange device driven by electromagnetic solenoid valves. All experiments were performed at room temperature (22-26°C) Material. Fura-2 AM (WAKO), nifedipine (Calbiochem), and CPA (Calbiochem) were used for Ca 2ϩ imaging. Indomethacin (Biomol), dexamethasone (Calbiochem), NF-B cell-permeable inhibitory peptide SN-50 (Calbiochem), curcumin (Biomol), NFAT activation inhibitor III (NAI-III) (Calbiochem), FK506 (Fermentek), and cyclosporin A (Calbiochem) were added into culture medium. EZ-Link Sulfo-NHS-SS-Biotin (Pierce) and avidin beads (Sigma) were used for biotinylation assay.
Human Stealth siRNAs, TRPC1-HSS110981 (AUAUUUAGAAGU-CCGAAAGCCAAGU, ACUUGGCUUUCGGACUUCUAAAUAU), TRPC1-HSS110982 (AUAUCAAGACGAAACCUGGAAUGCC, GGC-AUUCCAGGUUUCGUCUUGAUAU), and ORAI1-HSS131371 (AC-CGAGUUGAGAUUGUGCACGUUGC, GCAACGUGCACAAUCUC-AACUCGGU) (Invitrogen) were used for silencing according to the (11) . The stimulatory effects of proinflammatory cytokines such as TNF-␣ and IL-1␤ on PGE 2 production are well documented in various types of cells (14, 22) . Therefore, in the first step of this study, we explored the effects of TNF-␣ on COX mRNA expression and PGE 2 production in CCD18Co myofibroblasts.
As shown in Fig. 1A , at the mRNA level, the expression of COX-1 was constitutive in CCD-18Co and unresponsive to Ca: representative immunoblots for total TRPC1 and stromal interacting molecule 1 (STIM1) (top), biotinylated plasma membrane TRPC1 proteins (bottom) in untreated or TNF-␣ (50 ng/ml)-stimulated CCD-18Co cells. ␤-actin and biotin-labeled Na ϩ /K ϩ ATPase ␣1 (Biotin-NKA) were used as internal controls for total protein fraction and cell membrane fraction, respectively. Cb: timedependent changes in TRPC1 or STIM1 protein expression relative to internal control averaged from 4 individual experiments. *P Ͻ 0.05 against untreated cells. Fig. 1Ab ). In contrast, that of COX-2 was progressively upregulated by TNF-␣ treatment (solid bars in Fig. 1Ab) . Only 1 h after the addition of TNF-␣ in culture medium, a significant elevation in COX-2 mRNA expression was detected. In parallel with the induction of COX-2, TNF-␣ significantly increased the rate of PGE 2 production in time-and dose-dependent manners ( in Fig. 1, B and C) .
TNF-␣ (50 ng/ml) treatment (open bars in
It has been reported that PGE 2 production stimulated by TNF-␣ may be Ca 2ϩ dependent (25, 47) . We thus tested the effects of extra-and intracellular Ca 2ϩ buffering with EGTA (1 mM) and BAPTA-AM (10 M), respectively. Both procedures suppressed TNF-␣-induced PGE 2 production (Fig. 1B) . In addition, consistent with previous reports, the enhancing effects of TNF-␣ on PGE 2 production were almost completely blocked by the simultaneous addition of anti-inflammatory agents, indomethacin (INDO, 10 M) or dexamethasone (DEX, 100 nM) (Fig. 1C) (14) . Fig. 2A, a and b, respectively, a rapid rise in [Ca 2ϩ ] i was evoked by reintroduction of extracellular Ca 2ϩ (1 mM) after store depletion. In CCD-18Co cells treated with TNF-␣ (50 ng/ml) for 24 h, the magnitude of this [Ca 2ϩ ] i rise was multifold larger than that in untreated cells, whereas basal Ca 2ϩ influx visualized by the removal of Ca 2ϩ from the bath remained unchanged ( Fig. 2Aa; Supplemental Fig. S1 ; supplemental material for this article is available online at the 
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Physiology website). Importantly, the [Ca 2ϩ ] i rise induced by store depletion was significantly suppressed by the so-called SOC inhibitors Gd 3ϩ (5 M) and SK&F96365 (1 M), respectively ( Fig. 2A, a and b) . These results indicate that TNF-␣ treatment upregulates a store-dependent Ca 2ϩ influx. It has been suggested that several members of TRPC channels contribute to SOC in other types of cells (1, 41, 46) . We therefore examined the expression profile of TRPC mRNAs in CCD-18Co myofibroblasts. The RT-PCR analysis detected five TRPC mRNAs in the CCD-18Co, i.e., TRPC1, TRPC3, TRPC4, TRPC5, and TRPC6. Of these isoforms, only the expression of TRPC1 mRNA was significantly enhanced by TNF-␣ treatment (Fig. 2B) . Consistent with this observation, both total and biotin-labeled surface levels of TRPC1 protein were significantly increased by TNF-␣ treatment of more than 18 h (Fig. 2C) . A similar time course of the enhancing effects of TNF-␣ on store-dependent Ca 2ϩ influx was observed (⌬ratio 340/380; 0.13 Ϯ 0.04 at 0 h, 0.62 Ϯ 0.08 at 18 h, and 1.09 Ϯ 0.20 at 28 h; P Ͻ 0.05 with Dunnett's test). In contrast, the expression level of the ER Ca 2ϩ -sensor/signal protein STIM1 (Fig. 2C) or a SOC pore-forming molecule Orai1 (Supplemental Fig. S2A ) remained unchanged after TNF-␣ treatment. These observations suggest that augmentation of store-dependent Ca 2ϩ influx may be associated in some way with the increased protein expression of TRPC1, which is presumably responsible for TNF-␣-induced PGE 2 production. 2 production in CCD-18Co cells. To more directly corroborate the involvement of TRPC1-associated Ca 2ϩ influx in TNF-␣-induced PGE 2 production, stealth siRNA (siC1) was employed to specifically eliminate TRPC1 protein expression in CCD-18Co cells. As shown in Fig. 3A , two distinct siC1s employed successfully decreased the expression Fig. 4 . Induction of cationic conductance by a store-depleting agent thapsigargin. A: representative traces of inward currents induced by 2 M thapsigargin (TG) under the voltage-clamp at Ϫ60 mV with (c) and without (a, b) pretreatment with TNF-␣ (50 ng/ml) for 24 h. In a and b, the external solution was rapidly changed to 20 or 100 mM Ca 2ϩ -containing external solutions. Vertical deflections represent membrane current induced by ramp voltages (Ϫ100 -100 mV, 2 s). B: current-voltage relationships evaluated by the ramps with (black dashed) and without (gray solid) TNF-␣ pretreatment. The results show the averages from 7 and 6 cells, respectively. Short vertical bars denote SE. Ca: current density of TG (2 M)-induced currents recorded at Ϫ60 mV from CCD18Co cells without treatment (con), treated with TNF-␣ (50 ng/ml), or subjected to siRNA silencing for negative control (siCon) or TRPC1 (siC1) for 24 h. Cb: relative amplitude of TG-induced current remaining in the presence of 5 M Gd 3ϩ . The numbers in the parentheses indicate the number of experiments performed. *Statistically significant difference with unpaired t-test (P Ͻ 0.05).
TRPC1-associated Ca 2ϩ influx negatively regulates TNF-␣-induced PGE
level of TRPC1 protein, whereas control siRNA (siCon) exerted no inhibitory effect at the same concentration (Fig. 3Aa) . With the same transfection protocol, the basal production of PGE 2 was not affected by either of the two siC1s, but TNF-␣-induced PGE 2 production was enhanced by them more than twofold (Fig. 3Ab) . Overexpression of TRPC1 in CCD-18Co cells (Fig. 3Ba) produced the opposite consequence, i.e., significant suppression of TNF-␣-induced PGE 2 production (Fig.  3Bb) . These results strongly suggest that upregulation of TRPC1 may negatively regulate PGE 2 production during TNF-␣ treatment.
To confirm that TRPC1 actually contributes to store-dependent Ca 2ϩ influx in CCD-18Co, we next tested the effect of siC1. Compared with siCon, specific knockdown of TRPC1 by siC1 greatly attenuated the TNF-␣-induced enhancement of store-dependent Ca 2ϩ influx (Fig. 3C) . In addition, we tested the consequence of the knockdown of Orai1 by its specific siRNA, but no significant suppression was observed for the enhancement of the Ca 2ϩ influx by TNF-␣ pretreatment (Supplemental Fig. S2 ). These results lend a strong support to the essential contribution of TRPC1 to TNF-␣-induced enhancement of Ca 2ϩ influx in CCD-18Co cells. Nonselective cationic conductance induced by a store-depleting agent thapsigargin in CCD-18Co cells. It has often been a matter of debate that store-dependent Ca 2ϩ influx actually reflects the induction of Ca 2ϩ -permeable membrane conductance. We therefore attempted the direct recording of ionic currents accompanying store depletion by the patchclamp technique. As demonstrated in Fig. 4A , a noisy long-lasting inward current (or conductance) with double voltage-dependent rectifications (Fig. 4B) was elicited in response to a store-depleting agent thapsigargin (TG; 2 M) at a holding potential of Ϫ60 mV. When the external concentration of Ca 2ϩ was suddenly elevated to 20 or 100 mM, only small inward conduction of Ca 2ϩ was observed (Fig. 4A, a and b) . The reversal potential of TG-induced current was shifted from Ϫ1.65 Ϯ 2.6 (n ϭ 8) (Fig. 4B) to Ϫ37.35 Ϯ 0.72 mV (n ϭ 4) by changing the ionic composition of the bath from normal to 100 mM Ca 2ϩ -containing conditions, suggesting that the channel underlying is non- Pretreatment with 50 ng/ml of TNF-␣ enhanced the magnitude of TG-induced current almost threefold (Fig. 4 , Ac and Ca), which was specifically counteracted by the knockdown of TRPC1 expression with its specific siRNA (Fig. 4Ca) and greatly suppressed by Gd 3ϩ at its concentration (5 M) to block store-dependent Ca 2ϩ influx (Fig. 4Cb vs. Fig. 2Ab ). The above-described nature of TG-induced inward current in CCD-18Co cells is reminiscent of that observed for heterologously expressed TRPC1 (34) (16). Although we could not obtain the compelling evidence for the direct contribution of TRPC1 to storedependent Ca 2ϩ influx as a SOC pore-forming subunit, the above results are still consistent with the primary role of TRPC1 in regulating store-dependent Ca 2ϩ influx in CCD18Co cells. 2 production. The results of the siRNA experiments suggest that increased expression of TRPC1 (and enhanced SOC activity) parallels with the decreased PGE 2 production. However, it does not necessarily mean that TRPC1-mediated Ca 2ϩ influx directly regulates PGE 2 production. We therefore examined the effects of direct blockade of the Ca 2ϩ influx by a functional antibody T1E3, which reportedly inhibits Ca 2ϩ influx through TRPC1 channel from the cell exterior (42) . As shown in Fig. 5A , 24-h pretreatment with T1E3 antibody (diluted 1:200) significantly reduced store-dependent Ca 2ϩ influx by ϳ40%. Strikingly, this antibody enhanced the expression of COX-2 and production of PGE 2 induced by TNF-␣ treatment (Fig. 5, B and C) . In contrast, another antibody (T1) raised against the 15 amino acids in the second intracellular loop of TRPC1 protein (=QLYDKGYTSKEQKDC=) was totally ineffective when applied externally and could not prevent the TNF-␣-induced enhancement of store-operated Ca 2ϩ influx, COX-2 expression, or PGE 2 production (Fig. 5, A-C) . Similar to T1E3 antibody, a nonspecific SOC inhibitor SK&F96365 (1 M) produced enhancing effects on TNF-␣-induced COX-2 expression (Fig. 5B) . These results strongly suggest that, during TNF-␣ stimulation, TRPC1-associated Ca 2ϩ influx exerts a negative feedback on COX-2 induction, thereby limiting the extent of PGE 2 production.
Inhibition of TRPC1-associated store-dependent Ca 2ϩ influx by T1E3-antibody also accelerates TNF-␣-induced COX-2 upregulation and PGE
Involvement of NF-B-and calcineurin-NFAT-signaling in TNF-
] i activates downstream transcriptional activities such as NFAT and NF-B. In colon carcinoma cell as well as other types of cells, calcineurin-NFAT-and NF-B-mediated signalings have been implicated in the transcriptional control of COX-2 and TRPC1 (5, 7, 13). We therefore explored the possible link between TNF-␣-enhanced Ca 2ϩ influx and COX-2-dependent PGE 2 production in CCD-18Co cells, in terms of these two transcription factors by applying their inhibitors simultaneously with TNF-␣. As summarized in Fig. 6 , inhibitors for NF-B (curcumin, SN-50) significantly suppressed TNF-␣-induced COX-2 expression and PGE 2 production (Fig. 6A) . In contrast, the inhibition of NFAT activity by NAI-III peptide potentiated it (Fig. 6B) , as observed for the effects of TRPC1 inhibition by its siRNA or antibody. A similar extent of potentiation was also observed with a calcineurin inhibitor FK506 (Fig. 6Bb) .
We also tested whether the inhibition of these transcription factors affect the enhancing effects of TNF-␣ on TRPC1 protein expression and Ca 2ϩ influx in CCD-18Co cells. Whereas NF-B inhibitors (curcumin and SN-50) strongly counteracted the enhancement of TRPC1 expression and Ca 2ϩ influx by TNF-␣, the inhibitors of calcineurin-NFAT signaling (FK506 or NAI-III) were almost without effect (Fig. 6C) .
These results together suggest that, in CCD-18Co cells, activation of NF-B signaling is essential for TNF-␣-induced TRPC1 upregulation, COX-2 expression, and PGE 2 production. In contrast, activation of NFAT is rather modulatory, acting as a negative feedback regulator to limit the COX-2 upregulation and PGE 2 production induced by TNF-␣ at the downstream of TRPC1/SOC signaling.
Inhibition of TRPC1-mediated Ca 2ϩ influx accelerates NF-B signaling. We finally examined whether there is a cross talk between TRPC1-associated Ca 2ϩ influx/NFAT and TNF-␣/NF-B signalings. For this purpose, we tested the effects of T1E3 antibody and NFAT inhibitor (NAI-III) on IB␣ degradation and subsequent NF-B/p65 nuclear translocation by immunoblot analysis.
Twenty-four-hour pretreatment of CCD-18Co cells with TNF-␣ caused the degradation of IB␣ and paralleled decrease and increase in the cytoplasmic and nuclear levels of NF-B/ p65 protein, respectively (Fig. 7 , Aa and Ba). The same procedure also facilitated the nuclear translocation of NFAT3, the major isoform assigned to TNF-␣-induced COX-2 expression in other cell types (28, 43) (Fig. 7 , Ab and Bb). When T1E3 antibody was cotreated with TNF-␣ for 24 h, the extent of TNF-␣-induced degradation of IB␣ as well as that of the nuclear translocation of NF-B/p65 protein were further enhanced (Fig. 7 , Aa and Ba). Essentially the same results were obtained with siRNA knockdown of TRPC1 (Fig. 7 , Ab and Bb), which conversely attenuated the TNF-␣-induced nuclear translocation of NFAT3 (Fig. 7 , Ab and Bb). In contrast, the inhibition of NFAT signaling by NAI-III exerted only marginal effects on TNF-␣-induced IB degradation or NF-B translocation (Fig. 7 , Aa and Ba), despite its clear enhancing actions on COX-2 expression and PGE 2 production (Fig. 6) . In aggregate, these results can most straightforwardly suggest that activation of TRPC1-associated Ca 2ϩ influx may counteract the IB degradation and NF-B/p65 nuclear translocation induced by TNF-␣ via a pathway independent of NFAT signaling.
Finally, somewhat unexpectedly from the above results, rigorous deprivation of extracellular Ca 2ϩ (by adding 1 mM EGTA to Ca 2ϩ -free external solution) rather resulted in significant inhibition of NF-B/p65 translocation to the nucleus under TNF-␣ stimulation (Fig. 7 , Ac and Bc). These results raise the idea that, in addition to the degradation of NF-B/ I-B complex, the inductive effects of TNF-␣ on COX-2/PGE 2 production (Fig. 1 ) may require additional Ca 2ϩ influx through an unknown pathway(s) distinct from the TRPC1-associated one.
DISCUSSION
The principal finding of this study is that PGE 2 production in CCD-18Co cells, which is stimulated by the major inflammatory cytokine TNF-␣, is negatively regulated by TRPC1-associated Ca 2ϩ influx. This is supported by the specific knockdown or overexpression of TRPC1 protein or direct blockade of TRPC1-associated Ca 2ϩ influx by T1E3 antibody (Figs. 3 and 5) . Part of the TRPC1-mediated negative regulation seems to occur through activation of NFAT signaling, as siRNA knockdown of TRPC1 inhibited the nuclear translocation of NFAT3 (Fig. 7Bb) and calcineurin/NFAT inhibitors significantly potentiated the induction of COX-2 and subsequent PGE 2 production during TNF-␣ treatment (Fig. 6) . However, more direct inhibition of NF-B signaling through TRPC1-associated Ca 2ϩ influx may also be involved therein, as evidenced by NFAT-independent facilitating effects of T1E3 antibody and siRNA knockdown of TRPC1 on IB degradation and NF-B/p65 nuclear translocation (Fig. 7) . In addition, other lines of evidence indicate that, in CCD-18Co cells, TNF-␣ can induce the expression of COX-2 and TRPC1 proteins via a NF-B-dependent signaling pathway (Figs. 1, 2 , and 6), and the former appears to require Ca 2ϩ from a source distinct from TRPC1-associated Ca 2ϩ entry pathway (Figs. 1B and 7Bc). These observations collectively suggest that Ca 2ϩ -mediated signalings play multiple roles in regulating COX-2/ PGE 2 production in CCD-18Co cells, and that enhanced Ca 2ϩ influx attributable to increased TRPC1 expression may act as an effective negative feedback mechanism that limits TNF-␣-induced PGE 2 production both directly and indirectly through NF-B signaling (for summary, see Fig. 8 ).
Consultation with previous studies reveals that both cox-2 and trpc1 genes are subject to transcriptional control of NF-B (23, 29) . In fact, there are several consensus motifs present for NF-B binding in the 5=-regulatory regions of these genes (Supplemental Fig. S3A ). Some of them have been confirmed to be functional by DNA decoy assays (31, 37) , and our present data support the vital role of NF-B signaling in controlling these genes in CCD-18Co cells. Similar promoter analysis also suggests the existence of consensus motifs for NFAT binding in these genes (Supplemental Fig. S3B ). There are in vitro studies indicating that Ca 2ϩ -dependent activation of NFAT causes upregulation of COX-2 and TRPC1 proteins (26, 45) . However, in CCD-18Co cells, activation of calcineurin/NFAT pathway seems ineffective at regulating TRPC1 expression (Fig. 6Ca) and instead counteracts TNF-␣-induced COX-2 expression/PGE 2 production at the downstream of TRPC1-mediated signaling. The results of immunoblot analysis also suggest that activation of NFAT (presumably NFAT3) signaling occurs at the downstream of Ca 2ϩ influx associated with TRPC1 (Fig. 7, Ab and Bb) . This discrepancy could most simplistically be ascribed to differences in the cell type and receptor agonist involved, which may activate differential Ca 2ϩ signaling linking to distinct transcriptional pathways. Despite the crucial role of TRPC1-associated Ca 2ϩ influx in inhibiting NF-B activation by TNF-␣, the mechanism underlying it is presently unclear. However, a similar TRPC1-mediated negative regulation has been reported in intestinal epithelial cells. In these cells, stable overexpression of TRPC1 protein promotes TNF-␣-induced apoptosis via inhibition of NF-B activation. This is associated with enhanced storeoperated Ca 2ϩ influx that stimulates the phosphatase 2A (PP2A) activity to prevent the nuclear translocation of NF-B dimeric proteins. Thus the role of the Ca 2ϩ influx is stabilization of the PP2A complex, which in turn leads to dephosphorylation of IB proteins and inhibition of NF-B signaling (20) . Because PP2A is ubiquitously expressed and intimately involved in intestinal mucosal homeostasis (20, 21) , this enzyme may also participate in TRPC1/SOC-mediated inhibition of NF-B signaling in CCD-18Co cells (Fig. 8) .
The observed Ca 2ϩ dependence of TNF-␣-induced PGE 2 production (Fig. 1) favors the involvement of Ca 2ϩ -dependent process(es) therein. Because the NFAT-mediated pathway is inhibitory to COX-2 expression/PGE 2 production, it is reasonable to assume that some steps in activating NF-B signaling may be Ca 2ϩ dependent and facilitatory. In agreement with this possibility, the rate-limiting step of NF-B activation, i.e., degradation of IB and subsequent nuclear translocation of NF-B p65 protein, was significantly inhibited by vigorous Ca 2ϩ chelation with EGTA (Fig. 7 , Ac and Bc). It has been reported that activation of Ca 2ϩ -dependent transcription pathways depend differentially on the magnitude and pattern of [Ca 2ϩ ] i elevation. For example, in lymphocytes, NFAT is activated in response to a small but sustained [Ca 2ϩ ] i elevation or [Ca 2ϩ ] i oscillations at high frequency, whereas a large transient rise in [Ca 2ϩ ] i is sufficient for the activation of NF-B. These differences may be accounted for by fast switching of NFAT activation/inactivation cycle by the calcineurin/kinase system vs. rather slow reversal of NF-B activation attributable to proteolytic regulation of IB proteins by the ubiquitin/proteasome-mediated system (18, 39) . Seemingly consistent with this picture, our preliminary data show that a robust [Ca 2ϩ ] i transient can be elicited within tens of seconds after administration of TNF-␣ (supplemental Fig. S4 ), which is followed by increased expression of COX-2 mRNA detectable in an hour. In contrast, the expression level of TRPC1 starts to increase in a few hours after the addition of TNF-␣ with enhanced store-dependent Ca 2ϩ influx, which then causes more sustained [Ca 2ϩ ] i elevation. Thus one plausible scenario depicted from the present results is that enhanced Ca 2ϩ dynamics during TNF-␣ stimulation may produce two distinct Ca 2ϩ -dependent consequences, initial activation of NF-B signaling inducing COX-2 and TRPC1 upregulation and later activation of NFAT signaling via increased TRPC1-associated Ca 2ϩ influx, which decelerates the induction of COX-2 and resultant PGE 2 production. The extent and time course of these two regulations may be variable depending on the intensity and duration of TNF-␣ stimulation, which might correspond to different stages of bowel inflammation or disease with differential clinical severity.
It is well known that PGE 2 exerts both pro-and anti-inflammatory responses in a cell context-dependent manner (36) . For example, studies with the prostaglandin receptor EP4-deficient mice support the protective role of PGE 2 -EP4 signaling against gut inflammation. Disrupting the function of EP4 results in reduced expression of genes responsible for intestinal tissues defense, remodeling, and suppression of immune response, thus exacerbating experimentally induced colitis (12) . A different line of evidence suggests that spontaneous production of PGE 2 in intestinal stromal cells (myofibroblasts) residing in lamina propria is essential for the suppression of immune response to nonpathogenic dietary antigen or establishment of oral tolerance (24) . These findings together suggest that, under physiological conditions, basal PGE 2 production may play a pivotal role in maintaining intestinal mucosal integrity, barrier function, and homeostasis. In contrast, when PGE 2 production is abnormally stimulated, the activation of PGE 2 signaling may lead to aggravation of inflammation and induction of tumorigenicity (24) . In fact, in a mouse model of colitis, high-dose administration of PGE 2 analogs has been shown to markedly exacerbate inflammatory responses in the colon characterized by hyperemia, ulceration, and necrosis, whereas its low-dose administration causes only marginal effects. These deleterious actions of PGE 2 are likely associated with stimulation of the release of interleukin 23 from activated dendric cells, which in turn facilitate the differentiation of helper T lymphocytes to the proinflammatory phenotype Th17 (33) . These dose-dependent opposing actions of PGE 2 may imply that the extent of its production is crucial to determine the fate of intestinal mucosa, i.e., maintenance of integrity or disintegration. In this regard, the negative feedback regulation of PGE 2 production in intestinal myofibroblasts via TRPC1-associated Ca 2ϩ influx may be of significant clinical importance to protect the gut from exacerbation of inflammatory process and thus the progression of inflammatory bowel syndrome. Future animal studies with genetic deletion or in vivo siRNA knockdown of TRPC1 will more directly answer this possibility.
